Related to NeurOp Wins $3M from NIH to Progress NMDA Antagonist for Preventing Stroke

• CIRM Bankrolls 15 Stem Cell Research Grants with $40M
  
• NIH Doles Out $42M to Bolster the Human Microbiome Project
  
• Israeli Government Boosts Compugen Drug Discovery Funding with $400K
  
• Fast-Track and Atox Score $575K Grant to Move Septic Shock Treatment into Clinic
  
• NIH Sets Guidelines for Funding Research on Human Stem Cells
  
• Targacept to Receive $10M as AstraZeneca Scales Up CNS Disorder Partnership
  
• Merck & Co. Licenses Portola Phase II Stroke Therapy for $50M Up Front
  
• NIH Bankrolls $10M for Albert Einstein College of Medicine to Study Motion-Induced Enzyme Changes
  
• Human Genome Sciences Receives $151M Order for Anthrax Drug from U.S. Government
  
• PolyMedix and UMass Amherst Receive Five-Year NIH Biodefense Grant
  
• University of Rhode Island Wins $13M Grant to Develop Vaccines for Emerging Infectious Diseases
  
• Crucell and PATH Malaria Vaccine Program Get Funding to Develop a Prime-Boost Adenoviral Vaccine
  
• Apogenix Obtains Roughly $3.66M to Further Cancer and Inflammatory Disease Initiatives
  
• Neurotez Scores $2.73M to Progress Preclinical Leptin Therapy for Alzheimer’s Disease
  
• Grant to Pluristem Increased by $0.4M to Advance Cell Therapy for Critical Limb Ischemia
  
• Ichor and Partners Awarded $3.3M Grant to Develop Alzheimer’s Vaccine
  
• Thermo Fisher Scientific Sets Up RNAi Discovery Grant Program
  
• D-Pharm Raises $23M through Rights Offering and IPO
  
• Janssen to Invest at least $38M in CNS Collaboration with NeuroSearch
  
• SeqWright and Lilly to Sequence Genomic Regions Associated with Psychiatric Diseases Using Roche Technologies